Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02708433 · ClinicalTrials.gov registry record · NA
Clinical Outcomes of Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine
A NA study of Anesthesia, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT02708433: Completed NA study of Anesthesia, sponsored by University of North Carolina, Chapel Hill.
NCT02708433 is a NA study of Anesthesia that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 23 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02708433, a NA study of Anesthesia, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
Anecdotal data suggest that the buffered form of the local anesthetic is more potent at equal dosages, and a lower dosage of the drug might be used with an effect equal to higher dosage not buffered. Clinical data are needed to confirm these anecdotal data. No data exist comparing buffered local anesthetics at lower drug concentrations to current dosages commonly used in dental and oral surgical procedures
Primary Outcome
Subject's Mandibular first molar teeth tested before anesthetic and every 30 minutes after for response to Cold and Electric Pulp Test as reported by subjects as a "yes" or "no."
Conditions Studied
Interventions
- DRUG Lidocaine
Study Locations (1)
North Carolina
- UNC School of Dentistry - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT02708433 record still lists
NCT02708433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 1 intervention - of which Lidocaine is the first listed.
NCT02708433 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02708433 about?
NCT02708433 is a clinical study titled "Clinical Outcomes of Buffered 1% Lidocaine vs. Non-buffered 2% Lidocaine". Anecdotal data suggest that the buffered form of the local anesthetic is more potent at equal dosages, and a lower dosage of the drug might be used with an effect equal to higher dosage not buffered. Clinical data are needed to confirm these anecdotal data. No data exist comparing buffered local ane...
What is the current status of trial NCT02708433?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-03. Estimated completion is 2017-09.
What conditions does trial NCT02708433 study?
This clinical trial studies the following conditions: Anesthesia.
What interventions are being tested in trial NCT02708433?
The interventions under investigation include: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT02708433?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02708433 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02708433's enrollment target sits among peer trials
23 49th of 57 higher than 9 of 57 other Anesthesia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anesthesia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial
RECRUITING · NA
-
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
RECRUITING · NA
-
Pilot Feasibility Trial of the SafeLM Supraglottic Airway (SGA)
RECRUITING · NA
-
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
RECRUITING · NA
-
REcovery From DEXmedetomidine-induced Unconsciousness
RECRUITING · NA
-
Poke and a Placebo
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia